Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection—Systematic Review
Open Access
- 25 July 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8127
Abstract
Myocarditis (MC) is defined as an immunological inflammatory reaction with various etiologies, clinical presentations and prognoses within the myocardium. Currently, parvovirus B19 (PVB19) has become the main factor leading to this disease, replacing the previously dominant viruses A and B. In the case of chronic heart failure with subsequent dilated cardiomyopathy, approximately 67% have a viral etiology, and most of them are the result of PVB19 infection. However, the analysis showed a correlation between PVB19 infection and the risk of developing inflammatory dilated cardiomyopathy (DCMi). PVB19 is detected in 23% of patients with DCMi. Chronic infection may also contribute to progressive left ventricular failure in patients with a history of MC. The above effect suggests the active replication of PVB19 only in heart biopsies with inflammation due to MC or DCMi. Moreover, the supply of IFN-β to suppress the active transcription of PVB19 accompanied by DCMi over a period of 6 months results in the normalization of NT-proBNP and an improvement in LVEF along with NYHA performance. The small number of reports on this topic and inaccuracies resulting from constantly conducted research and ongoing changes make it impossible to clearly answer the question of whether PVB19 is a factor inducing de novo MC and DCM or only accompanies the above conditions. However, large clinical cohort studies lead to the perception of PVB19 as a viral etiological agent capable of causing de novo MC together with DCMi.Keywords
Funding Information
- Medical University of Białystok (B.SUB.24.305, SUB1/NN/22/001/2201, B.SUB.23.359, SUB/2/NN/22/001/2201)
- National Science Centre, Poland (B.SUB.24.305, SUB1/NN/22/001/2201, B.SUB.23.359, SUB/2/NN/22/001/2201)
This publication has 50 references indexed in Scilit:
- Fulminant myocarditis parvovirus B19 related in a young womanJournal of Artificial Organs, 2021
- An overview of the immune mechanisms of viral myocarditisReviews in Medical Virology, 2020
- Viral presence‐guided immunomodulation in lymphocytic myocarditis: an updateEuropean Journal of Heart Failure, 2020
- Inflammatory dilated cardiomyopathyHerz, 2020
- Viral Genome Search in Myocardium of Patients with Fulminant MyocarditisEuropean Journal of Heart Failure, 2020
- Fatal parvovirus B19 infections: a report of two autopsy casesInternational journal of legal medicine, 2018
- Cardiac Autoimmunity: Myocarditis2017
- Parvovirus B19 infection during pregnancy and risks to the fetusBirth Defects Research, 2017
- Relevance of Cardiac Parvovirus B19 in Myocarditis and Dilated Cardiomyopathy: Review of the LiteratureEuropean Journal of Heart Failure, 2016
- The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID)Herz, 2000